128 related articles for article (PubMed ID: 37708662)
1. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
Tang X; Li N; Hu Y
Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
[TBL] [Abstract][Full Text] [Related]
2. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
3. The survival impact of adjuvant radiotherapy and chemotherapy in patients with non-endometrioid endometrial carcinomas: a PSM-IPTW analysis based on SEER database.
Hao Z; Yu Y
BMC Womens Health; 2023 May; 23(1):278. PubMed ID: 37210506
[TBL] [Abstract][Full Text] [Related]
4. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
[TBL] [Abstract][Full Text] [Related]
5. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
[TBL] [Abstract][Full Text] [Related]
9. Malignant peritoneal cytology in endometrial cancer: a contemporary review.
Guo XM; Roman LD; Klar M; Wright JD; Matsuo K
Expert Rev Anticancer Ther; 2022 Sep; 22(9):947-955. PubMed ID: 35862462
[TBL] [Abstract][Full Text] [Related]
10. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
12. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
[TBL] [Abstract][Full Text] [Related]
13. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology.
Ogane N; Yasuda M; Kato H; Kato T; Yano M; Kameda Y; Kamoshida S
Cytopathology; 2018 Jun; 29(3):254-261. PubMed ID: 29626374
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X; Cao D; Zhou H; Wang T; Wang J; Zhang Y; Yu M; Cheng N; Peng P; Yang J; Huang H; Shen K
World J Surg Oncol; 2023 Mar; 21(1):106. PubMed ID: 36973753
[TBL] [Abstract][Full Text] [Related]
15. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
16. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
[TBL] [Abstract][Full Text] [Related]
17. Hormonal therapy or chemotherapy for early-stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study.
Matsuo K; Chen L; Guo XM; Roman LD; Klar M; Wright JD
Gynecol Oncol; 2022 May; 165(2):353-360. PubMed ID: 35227514
[TBL] [Abstract][Full Text] [Related]
18. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer.
Matsuo K; Matsuzaki S; Miller H; Nusbaum DJ; Walia S; Matsuzaki S; Shimada M; Klar M; Roman LD
J Surg Oncol; 2021 Sep; 124(4):687-698. PubMed ID: 34118157
[TBL] [Abstract][Full Text] [Related]
20. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]